Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
about
Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence.The association between the number of office visits and the control of cardiovascular risk factors in Iranian patients with type2 diabetesRethinking the frequency of between-visit monitoring for patients with diabetes.An evaluation of patients' adherence with hypoglycemic medications among Papua New Guineans with type 2 diabetes: influencing factorsFactors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesExtent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans.Integrating support persons into diabetes telemonitoring to improve self-management and medication adherenceMinimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).The Relationship Between Food Insecurity and Depression, Diabetes Distress and Medication Adherence Among Low-Income Patients with Poorly-Controlled Diabetes.Factors associated with medication information in diabetes care: differences in perceptions between patients and health care professionals.Illness perceptions of Libyans with T2DM and their influence on medication adherence: a study in a diabetes center in Tripoli.Medication adherence may be more important than other behaviours for optimizing glycaemic control among low-income adultsThe Usability of Diabetes MAP: A Web-delivered Intervention for Improving Medication AdherenceThe agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)Psychometric analysis of the Spanish and Catalan versions of the Diabetes Self-Care inventory-revised version questionnaire.Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control.Improving adherence and outcomes in diabetic patients.Empirical validation of the information-motivation-behavioral skills model of diabetes medication adherence: a framework for intervention.The association between the measurement of adherence to anti-diabetes medicine and the HbA1c.Adherence to diabetes medication: a systematic review.The MEssaging for Diabetes (MED) intervention improves short-term medication adherence among low-income adults with type 2 diabetes.Medication Adherence With Diabetes Medication: A Systematic Review of the Literature.Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.The MEssaging for Diabetes Intervention Reduced Barriers to Medication Adherence Among Low-Income, Diverse Adults With Type 2.Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study.mHealth Intervention Elements and User Characteristics Determine Utility: A Mixed-Methods Analysis.A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study.Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine.Glycaemic control and self-management behaviours in Type 2 diabetes: results from a 1-year longitudinal cohort study.Factors associated with glycemic status and ability to adapt to changing demands in people with and without type 2 diabetes mellitus: A cross-sectional study.Psychometric Evaluation of a Korean Version of the Adherence to Refills and Medications Scale (ARMS) in Adults With Type 2 Diabetes
P2860
Q33610427-2850B589-6A56-4E34-9801-9756FAE66234Q33859839-906983FF-B546-4954-8307-85AAF257E390Q33988355-51B4A242-197F-465F-9F7C-A3B3BBAF4195Q34229892-722EBAF1-ED5A-4227-B4E0-FDBC3E1545FEQ35043805-2E62EE4E-6F59-42CF-84F5-6858C185F9C0Q35136139-E8919A2F-8CF4-4D76-B869-D16FC903DFAEQ35152527-B83A9414-845F-4F12-BEE6-AB3FA399ADACQ35666228-7961F5B4-D680-4810-832F-5011BACCBE36Q36083915-D83945D5-975D-4FF4-BE7E-B7E56B9BFC2AQ36180779-A1A1225E-B267-483B-886D-16B0FAD9BFDAQ36415766-4577BDCA-5761-4A3A-AA24-24770125D6E6Q36913646-7F3E37C2-DB3F-4636-96B1-A66F3DA5841AQ37008526-EE625DC8-CA1B-485D-B55D-E1789DD157B4Q37063490-B9F9DE9A-3615-46FA-B8DC-5384D606FB90Q37225337-1CFECCB4-7181-456D-996D-753B63691431Q37516672-9B186164-A1CB-4E5F-BE67-0EA81D6EE386Q37561716-AA9FF1E9-DE92-453F-A20C-642032F1A7E1Q37652949-2B7F45D8-8547-4731-B844-0B548EACDEBAQ37715533-5AE87F3B-E634-44B6-83E1-19125BBF8870Q38202906-9DB7256F-D9BF-445F-9A8C-82DC75C1E21AQ38273831-0488F43B-64FA-42F1-A1FD-92028B4A35E5Q38378929-EB76C528-2D75-4CF1-B39A-9000E15D3D70Q38659210-9506E9D0-E348-411B-95A0-F8424DEA72F4Q39680117-E674DD89-FAA0-4114-923B-BB6A6C296015Q41692675-A8490CF3-9379-40BC-8A16-DC918E201A8AQ42376850-C28593BA-8CF5-4DAB-8D1E-B6B47007BCC8Q47113727-FA1E368F-F78B-4FF2-9E59-D4EB1506C7B9Q47557571-49AB4148-B2C1-40A5-80E9-03564451F756Q49219278-20D778BD-3325-42AF-BDE5-99A93E85E0CBQ50975586-DF3D1304-6466-41AF-9C41-3AE6920D719BQ55011758-B429819F-A592-4D36-A9F1-FE8FED9D88B5Q58534491-27F8AEEC-63F9-473A-99AF-B7613726631A
P2860
Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@ast
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@en
type
label
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@ast
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@en
prefLabel
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@ast
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@en
P2860
P356
P1433
P1476
Longitudinal association betwe ...... ic control in Type 2 diabetes.
@en
P2093
J D Piette
J E Aikens
P2860
P304
P356
10.1111/DME.12046
P577
2013-03-01T00:00:00Z